Activos Circulantes Cambio Fecha
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Amgen USD 31.48B 2.42B 2026-03
Arca Biopharma USD 395.25M 51.39M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Biogen USD 9.19B 216.3M 2026-03
Brainstorm Cell Therapeutics USD 184K 123K 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Capricor Therapeutics USD 283.09M 39.85M 2026-03
Cytokinetics USD 839.46M 77.51M 2026-03
Eisai JPY 761.64B 79.24B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Exelixis USD 1.21B 234.65M 2026-03
Geron USD 498.53M 21.74M 2026-03
Halozyme Therapeutics USD 1B 177.83M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Ligand Pharmaceuticals USD 865.42M 33.14M 2026-03
Merck USD 35.02B 8.5B 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 42.82B 76M 2026-03
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03